Y Otani

1.2k total citations
36 papers, 975 citations indexed

About

Y Otani is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, Y Otani has authored 36 papers receiving a total of 975 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pulmonary and Respiratory Medicine, 11 papers in Surgery and 11 papers in Oncology. Recurrent topics in Y Otani's work include Gastric Cancer Management and Outcomes (13 papers), Gastrointestinal Tumor Research and Treatment (4 papers) and Metastasis and carcinoma case studies (4 papers). Y Otani is often cited by papers focused on Gastric Cancer Management and Outcomes (13 papers), Gastrointestinal Tumor Research and Treatment (4 papers) and Metastasis and carcinoma case studies (4 papers). Y Otani collaborates with scholars based in Japan, United States and United Kingdom. Y Otani's co-authors include Tetsuro Kubota, Masaki Kitajima, Markku Kurkinen, Edward D. Harris, Juan Saus, S Quiñones, Koichiro Kumai, Hideaki Nagase, Masaru Mukai and Yuko Kitagawa and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Hepatology.

In The Last Decade

Y Otani

35 papers receiving 946 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Y Otani Japan 12 348 279 267 248 192 36 975
Ken-ichi Inada Japan 23 478 1.4× 277 1.0× 642 2.4× 366 1.5× 165 0.9× 60 1.7k
Jens C. Hahne United Kingdom 21 493 1.4× 527 1.9× 636 2.4× 387 1.6× 118 0.6× 65 1.5k
Tsu‐Yao Cheng Taiwan 20 237 0.7× 365 1.3× 775 2.9× 301 1.2× 112 0.6× 42 1.4k
Alexander Schlachterman United States 18 232 0.7× 296 1.1× 496 1.9× 65 0.3× 83 0.4× 75 1.7k
Kenji Oyama Japan 18 148 0.4× 344 1.2× 548 2.1× 170 0.7× 34 0.2× 37 1.3k
Hitoshi Ura Japan 21 205 0.6× 692 2.5× 297 1.1× 252 1.0× 20 0.1× 42 1.2k
Tomohiro Kurokawa Japan 16 141 0.4× 347 1.2× 271 1.0× 81 0.3× 18 0.1× 66 1000
M Moorghen United Kingdom 20 191 0.5× 449 1.6× 485 1.8× 226 0.9× 43 0.2× 35 1.4k
Yoshiki Naito Japan 21 358 1.0× 979 3.5× 436 1.6× 404 1.6× 27 0.1× 147 1.7k
G. H. Millward‐Sadler United Kingdom 16 114 0.3× 193 0.7× 195 0.7× 139 0.6× 13 0.1× 28 970

Countries citing papers authored by Y Otani

Since Specialization
Citations

This map shows the geographic impact of Y Otani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Y Otani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Y Otani more than expected).

Fields of papers citing papers by Y Otani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Y Otani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Y Otani. The network helps show where Y Otani may publish in the future.

Co-authorship network of co-authors of Y Otani

This figure shows the co-authorship network connecting the top 25 collaborators of Y Otani. A scholar is included among the top collaborators of Y Otani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Y Otani. Y Otani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Otani, Y, et al.. (2024). The focal adhesion protein talin is a mechanically gated A-kinase anchoring protein. Proceedings of the National Academy of Sciences. 121(13). e2314947121–e2314947121. 10 indexed citations
3.
Otani, Y, Naohiko Kohtake, & Yoshiaki Ohkami. (2013). Dual-Use system architecture for a space situational awareness system in Japan. 1–8. 3 indexed citations
5.
6.
Nakamura, Tetsuya, Masashi Yoshida, Y Otani, et al.. (2006). Twelve years’ progress in surgery for perforated gastric and duodenal ulcers: a retrospective study of indications for laparoscopic surgery, post‐operative course and the influence of Candida infection. Alimentary Pharmacology & Therapeutics. 24(s4). 297–302. 4 indexed citations
7.
Otani, Y, Masashi Yoshida, Yoko Saikawa, et al.. (2006). Discrimination between gastric ectopic pancreas and mesenchymal tumours, including GIST – from 12 years‘ surgical experience in one institute. Alimentary Pharmacology & Therapeutics. 24(s4). 292–296. 4 indexed citations
8.
Yoshimizu, Nobunari, Y Otani, Yutaka Saikawa, et al.. (2004). Anti‐tumour effects of nobiletin, a citrus flavonoid, on gastric cancer include: antiproliferative effects, induction of apoptosis and cell cycle deregulation. Alimentary Pharmacology & Therapeutics. 20(s1). 95–101. 120 indexed citations
9.
Egawa, Tomohisa, Takeshi Kubota, Toru Furukawa, et al.. (2001). Docetaxel enhances the cytotoxicity of tetrahydropyranyladriamycin in a sequence-dependent manner.. PubMed. 21(4A). 2597–600. 1 indexed citations
10.
Otani, Y, Naoto Kurihara, Yoshihiko Sakurai, et al.. (2000). Matrix metalloproteinase expression in cultured human gastric wall fibroblasts – interactions with Helicobacter pylori isolated from patients with ulcers. Alimentary Pharmacology & Therapeutics. 14(s1). 193–198. 18 indexed citations
11.
Abe, Satoshi, Tetsuro Kubota, Sachiko Matsuzaki, et al.. (2000). Chemosensitivity test is useful in evaluating the appropriate adjuvant cancer chemotherapy for stage III non-scirrhous and scirrhous gastric cancers.. PubMed. 19(5C). 4581–6. 16 indexed citations
12.
Kokuba, Yukihito, Y Otani, Akiyoshi Kakita, & Katsuko Yamashita. (1999). [Establishment of alpha-fetoprotein producing human rectal cancer cell line (RKK-YK) and its features].. PubMed. 96(7). 809–16.
13.
Kubota, Tetsuro, et al.. (1999). Management of primary gastric lymphomas from a surgeon's viewpoint.. Oncology Reports. 6(1). 103–6. 4 indexed citations
14.
Kubota, Tetsuro, Mamoru Watanabe, Yasuro Kawano, et al.. (1999). Interferon gamma increases the antitumor activity of mitomycin C against human colon cancer cells in vitro and in vivo.. Oncology Reports. 6(3). 621–5. 2 indexed citations
15.
Otani, Y, et al.. (1998). Long Term Survival and Quality of Life after Minimally Invasive Surgery for Early Gastric Cancer.. The Japanese Journal of Gastroenterological Surgery. 31(4). 1015–1019. 1 indexed citations
16.
Kurihara, Naoto, Tetsuro Kubota, Y Otani, et al.. (1998). Lymph node metastasis of early gastric cancer with submucosal invasion. British journal of surgery. 85(6). 835–839. 92 indexed citations
17.
Kubota, Tetsuro, Y Otani, T Teramoto, et al.. (1998). MKT-077, localized lipophilic cation: antitumor activity against human tumor xenografts serially transplanted into nude mice.. PubMed. 18(2A). 1047–52. 23 indexed citations
18.
Okazaki, Isao, Norihito Wada, Masayuki Nakano, et al.. (1997). Difference in Gene Expression for Matrix Metalloproteinase–1 Between Early and Advanced Hepatocellular Carcinomas. Hepatology. 25(3). 580–584. 34 indexed citations
19.
Kubota, Tetsuro, et al.. (1997). Interferons alpha-2a and beta increase the antitumor activity, detected by MTT assay, of 5-fluorouracil against experimental and clinical human gastrointestinal carcinomas.. PubMed. 17(1B). 725–8. 10 indexed citations
20.
Saus, Juan, S Quiñones, Y Otani, et al.. (1988). The complete primary structure of human matrix metalloproteinase-3. Identity with stromelysin.. Journal of Biological Chemistry. 263(14). 6742–6745. 212 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026